[PDF][PDF] Different metabolic responses of human brown adipose tissue to activation by cold and insulin
…, V Oikonen, T Noponen, T Viljanen, M Scheinin… - Cell metabolism, 2011 - cell.com
We investigated the metabolism of human brown adipose tissue (BAT) in healthy subjects
by determining its cold-induced and insulin-stimulated glucose uptake and blood flow (…
by determining its cold-induced and insulin-stimulated glucose uptake and blood flow (…
Distribution of α2-adrenergic receptor subtype gene expression in rat brain
M Scheinin, JW Lomasney, DM Hayden-Hixson… - Molecular Brain …, 1994 - Elsevier
α 2 -Adrenergic receptors in brain are important presynaptic modulators of central noradrenergic
function (autoreceptors) and postsynaptic mediators of many of the widespread effects …
function (autoreceptors) and postsynaptic mediators of many of the widespread effects …
Gene targeting—homing in on α2-adrenoceptor-subtype function
E MacDonald, BK Kobilka, M Scheinin - Trends in pharmacological …, 1997 - cell.com
… Ewen MacDonald, Brian Kobilka and Mika Scheinin describe how these mice may be
utilized to elucidate the physiological functions of the receptor subtypes and the properties of …
utilized to elucidate the physiological functions of the receptor subtypes and the properties of …
Dexmedetomidine, an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery.
…, J Kanto, M Scheinin, A Kallio, H Scheinin - Anesthesiology, 1990 - europepmc.org
The effects of dexmedetomidine, an alpha 2-adrenoceptor agonist, on vigilance, thiopental
anesthetic requirements, and the hemodynamic, catecholamine, and hormonal responses to …
anesthetic requirements, and the hemodynamic, catecholamine, and hormonal responses to …
Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine
P Talke, CA Richardson, M Scheinin… - Anesthesia & …, 1997 - journals.lww.com
Dexmedetomidine is a selective alpha 2-adrenoceptor agonist with centrally mediated
sympatholytic, sedative, and analgesic effects. This study evaluated: 1) pharmacokinetics of …
sympatholytic, sedative, and analgesic effects. This study evaluated: 1) pharmacokinetics of …
[HTML][HTML] A randomized trial of a transglutaminase 2 inhibitor for celiac disease
…, Y Zopf, AW Lohse, M Scheinin… - … England Journal of …, 2021 - Mass Medical Soc
Background In celiac disease, small intestinal transglutaminase 2 causes deamidation of
glutamine residues in gluten peptides, which enhances stimulation of T cells and leads to …
glutamine residues in gluten peptides, which enhances stimulation of T cells and leads to …
Effects of dexmedetomidine, a selective α2‐adrenoceptor agonist, on hemodynamic control mechanisms
A Kallio, M Scheinin, M Koulu… - Clinical …, 1989 - Wiley Online Library
Dexmedetomidine, a selective α 2 ‐adrenoceptor agonist, was administered to five healthy
male volunteers in single intravenous doses of 12.5, 25, 50, and 75 µg as part of a placebo‐…
male volunteers in single intravenous doses of 12.5, 25, 50, and 75 µg as part of a placebo‐…
Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy
…, E Engblom, A Naum, K Någren, M Scheinin… - Circulation, 2008 - Am Heart Assoc
Background— The anti-ischemic agent trimetazidine improves ejection fraction in heart failure
that is hypothetically linked to inhibitory effects on cardiac free fatty acid (FFA) oxidation. …
that is hypothetically linked to inhibitory effects on cardiac free fatty acid (FFA) oxidation. …
Bioavailability of dexmedetomidine after intranasal administration
…, T Manner, R Aantaa, M Lahtinen, M Scheinin… - European journal of …, 2011 - Springer
Purpose The aim of this proof-of-concept study was to characterize the pharmacokinetics
and pharmacodynamics of intranasal dexmedetomidine compared with its intravenous …
and pharmacodynamics of intranasal dexmedetomidine compared with its intravenous …
Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6‐hydroxydopamine and 1‐methyl‐4‐phenyl‐1,2,3,6 …
…, J Kaslin, N Peitsaro, M Scheinin… - Journal of …, 2004 - Wiley Online Library
Dopaminergic deficiency in the brain of zebrafish was produced by systemic administration
of two catecholaminergic neurotoxins, 6‐hydroxydopamine (6‐OHDA) and 1‐methyl‐4‐…
of two catecholaminergic neurotoxins, 6‐hydroxydopamine (6‐OHDA) and 1‐methyl‐4‐…